Literature DB >> 1985459

Allele frequency estimation from data on relatives.

M Boehnke1.   

Abstract

Given genetic marker data on unrelated individuals, maximum-likelihood allele-frequency estimates and their standard errors are easily calculated from sample proportions. When marker phenotypes are observed on relatives, this method cannot be used without either discarding a subset of the data or incorrectly assuming that all individuals are unrelated. Here, I describe a method for allele frequency estimation for data on relatives that is based on standard methods of pedigree analysis. This method makes use of all available marker information while correctly taking into account the dependence between relatives. I illustrate use of the method with family data for a VNTR polymorphism near the apolipoprotein B locus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985459      PMCID: PMC1682747     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

2.  Variable number of tandem repeat (VNTR) markers for human gene mapping.

Authors:  Y Nakamura; M Leppert; P O'Connell; R Wolff; T Holm; M Culver; C Martin; E Fujimoto; M Hoff; E Kumlin
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

3.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region.

Authors:  E Boerwinkle; W J Xiong; E Fourest; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  High-resolution analysis of a hypervariable region in the human apolipoprotein B gene.

Authors:  E H Ludwig; W Friedl; B J McCarthy
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

5.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

6.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

7.  Extensions to pedigree analysis. V. Optimal calculation of Mendelian likelihoods.

Authors:  K Lange; M Boehnke
Journal:  Hum Hered       Date:  1983       Impact factor: 0.444

8.  Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type.

Authors:  G D Schellenberg; S S Deeb; M Boehnke; E M Bryant; G M Martin; T H Lampe; T D Bird
Journal:  J Neurogenet       Date:  1987-04       Impact factor: 1.250

9.  The frequency of C4B variants of complement in familial and sporadic Alzheimer disease.

Authors:  T D Bird; M Boehnke; J Anderson; T H Lampe; G Schellenberg; E B Larson
Journal:  Alzheimer Dis Assoc Disord       Date:  1987       Impact factor: 2.703

  9 in total
  88 in total

1.  Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters.

Authors:  H H Göring; J D Terwilliger
Journal:  Am J Hum Genet       Date:  2000-03-23       Impact factor: 11.025

2.  Statistical tests for detection of misspecified relationships by use of genome-screen data.

Authors:  M S McPeek; L Sun
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

3.  Linkage analysis of a complex pedigree with severe bipolar disorder, using a Markov chain Monte Carlo method.

Authors:  C Garner; L A McInnes; S K Service; M Spesny; E Fournier; P Leon; N B Freimer
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

4.  Paget disease of bone: mapping of two loci at 5q35-qter and 5q31.

Authors:  N Laurin; J P Brown; A Lemainque; A Duchesne; D Huot; Y Lacourcière; G Drapeau; J Verreault; V Raymond; J Morissette
Journal:  Am J Hum Genet       Date:  2001-07-25       Impact factor: 11.025

5.  A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees.

Authors:  E Lindholm; B Ekholm; S Shaw; P Jalonen; G Johansson; U Pettersson; R Sherrington; R Adolfsson; E Jazin
Journal:  Am J Hum Genet       Date:  2001-05-25       Impact factor: 11.025

6.  A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10.

Authors:  Satoko Shimizu; Charles Krafchak; Nobuo Fuse; Michael P Epstein; Miriam T Schteingart; Alan Sugar; Maya Eibschitz-Tsimhoni; Catherine A Downs; Frank Rozsa; Edward H Trager; David M Reed; Michael Boehnke; Sayoko E Moroi; Julia E Richards
Journal:  Am J Med Genet A       Date:  2004-11-01       Impact factor: 2.802

7.  HLA-DR polymorphism in a Senegalese Mandenka population: DNA oligotyping and population genetics of DRB1 specificities.

Authors:  J M Tiercy; A Sanchez-Mazas; L Excoffier; X Shi-Isaac; M Jeannet; B Mach; A Langaney
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

8.  Inclusion of data on relatives for estimation of allele frequencies.

Authors:  R Chakraborty
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

9.  Recurrent major depression and right hippocampal volume: A bivariate linkage and association study.

Authors:  Samuel R Mathias; Emma E M Knowles; Jack W Kent; D Reese McKay; Joanne E Curran; Marcio A A de Almeida; Thomas D Dyer; Harald H H Göring; Rene L Olvera; Ravi Duggirala; Peter T Fox; Laura Almasy; John Blangero; David C Glahn
Journal:  Hum Brain Mapp       Date:  2015-10-20       Impact factor: 5.038

10.  A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter.

Authors:  S Ghosh; E R Hauser; V L Magnuson; T Valle; D S Ally; Z E Karanjawala; J B Rayman; J I Knapp; A Musick; J Tannenbaum; C Te; W Eldridge; S Shapiro; T Musick; C Martin; A So; A Witt; J B Harvan; R M Watanabe; W Hagopian; J Eriksson; S J Nylund; K Kohtamaki; E Tuomilehto-Wolf; M Boehnke
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.